Prophylactic Ceftizoxime (Cefizox) for Elective Cesarean Delivery

Phase 4

Completed

• Conditions: Caesarean
• Interventions: Drug: ceftizoxime

• Registration Number: NCT01347593
• Lead Sponsor: University of Khartoum

Brief Summary

Ceftizoxime (Cefizox) will reduce post Cesarean delivery febrile morbidity.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-05
• Study First Submitted: 2011-05-02
• Study First Submitted QC: 2011-05-03
• Study First Posted: 2011-05-04
• Primary Completion: 2011-08
• Study Completion: 2011-08
• Status Verified: 2013-01
• Last Update Submitted: 2013-01-16
• Last Update Posted: 2013-01-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 220

Inclusion Criteria

• Elective Cesarean section

Exclusion Criteria

• Diabetes severe anaemia allergy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
ceftizoxime (cefizox) injection	ceftizoxime	ceftizoxime (cefizox) as single dose of 1 g at the interval of 30-60 minutes before the incision

Primary Outcome Measures

Name	Time	Method
reducing post Cesarean section febrile morbidity	4 days	reducing infection rate

Trial Locations

Locations (1)

Soba Hospital; 🇸🇩 Khartoum, Sudan